Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Van Hoof

Showing results (81-90 of 113) with videos related to

Pageof 12
Sort By:
Muscle & Nerve|September 1, 1981
Morphological and biochemical changes in muscle and peripheral nerve in Fabry's diseaseJ F Pellissier, F Van Hoof, D Bourdet-Bonerandi, et al.
Kidney International|November 1, 1980
Gentamicin-induced nephrotoxicity: a cell biology approachJ P Morin, G Viotte, A Vandewalle, et al.
Biochimie|January 1, 1972
Glycogen storage diseasesF Van Hoof, L Hue, T De Barsy, et al.
Biochemical Pharmacology|September 15, 1974
Commentary. Lysosomotropic agentsC de Duve, T de Barsy, B Poole, et al.
The Journal of Antimicrobial Chemotherapy|July 1, 1981
Prospective comparative study of the nephrotoxicity of aminoglycosides in human (abstract)M E De Broe, G Paulus, G A Verpooten, et al.
Bulletin De La Societe Belge D'Ophtalmologie|January 1, 1989
[Efficacy of treatments in experimental toxoplasmosis]M J Tassignon, M Brihaye, F De Meuter, et al.
Biological Mass Spectrometry|February 1, 1991
Study of reactions induced by hydroxylamine treatment of esters of organic acids and of 3-ketoacids: application to the study of urines from patients under valproate therapyR Libert, J P Draye, F Van Hoof, et al.
Neurology|July 1, 1988
Type 3 (chronic) GM1 gangliosidosis presenting as infanto-choreo-athetotic dementia, without epilepsy, in three sistersG C Guazzi, I D'Amore, F Van Hoof, et al.
Annales De La Societe Belge De Medecine Tropicale|January 1, 1977
[Comparative study of lysosomotropic chemotherapy of Chagas' disease and nagana]J M Jadin, A Trouet, F Van Hoof, et al.
Circulation|June 1, 1986
Changes in myocardial metabolism during therapy in patients with chronic stable angina: a comparison of long-term dosing with propranolol and nicardipineM F Rousseau, C Hanet, E Pardonge-Lavenne, et al.
Pageof 12

Showing results (81-90 of 113) with videos related to

Sort By:
Pageof 12
Muscle & Nerve|September 1, 1981
Morphological and biochemical changes in muscle and peripheral nerve in Fabry's diseaseJ F Pellissier, F Van Hoof, D Bourdet-Bonerandi, et al.
Kidney International|November 1, 1980
Gentamicin-induced nephrotoxicity: a cell biology approachJ P Morin, G Viotte, A Vandewalle, et al.
Biochimie|January 1, 1972
Glycogen storage diseasesF Van Hoof, L Hue, T De Barsy, et al.
Biochemical Pharmacology|September 15, 1974
Commentary. Lysosomotropic agentsC de Duve, T de Barsy, B Poole, et al.
The Journal of Antimicrobial Chemotherapy|July 1, 1981
Prospective comparative study of the nephrotoxicity of aminoglycosides in human (abstract)M E De Broe, G Paulus, G A Verpooten, et al.
Bulletin De La Societe Belge D'Ophtalmologie|January 1, 1989
[Efficacy of treatments in experimental toxoplasmosis]M J Tassignon, M Brihaye, F De Meuter, et al.
Biological Mass Spectrometry|February 1, 1991
Study of reactions induced by hydroxylamine treatment of esters of organic acids and of 3-ketoacids: application to the study of urines from patients under valproate therapyR Libert, J P Draye, F Van Hoof, et al.
Neurology|July 1, 1988
Type 3 (chronic) GM1 gangliosidosis presenting as infanto-choreo-athetotic dementia, without epilepsy, in three sistersG C Guazzi, I D'Amore, F Van Hoof, et al.
Annales De La Societe Belge De Medecine Tropicale|January 1, 1977
[Comparative study of lysosomotropic chemotherapy of Chagas' disease and nagana]J M Jadin, A Trouet, F Van Hoof, et al.
Circulation|June 1, 1986
Changes in myocardial metabolism during therapy in patients with chronic stable angina: a comparison of long-term dosing with propranolol and nicardipineM F Rousseau, C Hanet, E Pardonge-Lavenne, et al.
Pageof 12